Advertisement

High output cardiac failure

  • Inder S. Anand
  • Viorel G. Florea
Article

Opinion statement

Congestive heart failure describes a syndrome with complex and variable symptoms and signs, including dyspnea, increased fatigability, tachypnea, tachycardia, pulmonary rales, and peripheral edema. Although this syndrome usually is associated with low cardiac output, it may occur in a number of so-called high output states, when the cardiac output is normal or greater than normal. A high output state may occur in chronic severe anemia, large arteriovenous fistula or multiple small arteriovenous shunts as in Paget’s bone disease, some forms of severe hepatic or renal disorders, and acutely in septic shock. The syndrome of systemic congestion in a high output state is traditionally referred to as high output heart failure. However, the term is a misnomer because the heart in these conditions is normal, capable of generating very high cardiac output. The underlying problem in high output failure is a decrease in the systemic vascular resistance that threatens the arterial blood pressure and causes activation of neurohormones, resulting in an increase in salt and water retention by the kidney. Many of the high output states are curable conditions, and because they are associated with decreased peripheral vascular resistance, the use of vasodilator therapy for treatment of congestion may aggravate the problem. There are other clinically important issues in high output failure that have received little attention in the current medical literature. This article reviews the available data on high output cardiac failure with particular emphasis on the underlying mechanisms and treatment.

Keywords

Systemic Vascular Resistance Arteriovenous Fistula High Cardiac Output Polyostotic Fibrous Dysplasia Severe Septic Shock 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Anand IS, Chugh SS: Mechanisms and management of renal dysfunction in heart failure. Curr Opin Cardiol 1997, 12:251–8. A recent review of the afferent and efferent mechanisms of renal dysfunction in heart failure including the new developments in the management of salt and fluid retention in patients with congestive heart failure.PubMedCrossRefGoogle Scholar
  2. 2.
    Luft FC, Rankin LI, Bloch R, et al.: Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979, 60:697–706.PubMedGoogle Scholar
  3. 3.
    Cohn JN, Levine TB, Francis GS, Goldsmith S: Neurohumoral control mechanisms in congestive heart failure. Am Heart J 1981, 102:509–514.PubMedCrossRefGoogle Scholar
  4. 4.
    Riegger AJ, Liebau G: The renin-angiotensinaldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci 1982, 62:465–69.PubMedGoogle Scholar
  5. 5.
    Riegger GA, Liebau G, Bauer E, Kochsiek K: Vasopressin and renin in high output heart failure of rats: hemodynamic effects of elevated plasma hormone levels. J Cardiovasc Pharmacol 1985, 7:1–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Anand IS: Neurohormonal modulation in chronic heart failure. Dialogue Cardiovasc Med 1999, 4:63–73.Google Scholar
  7. 7.
    Anand IS: Pathogenesis of salt and water retention in the congestive heart failure syndrome. In Heart Failure. Edited by Poole-Wilson PA, Colucci WS, Massie BM, et al. New York: Churchill Livingstone; 1997:155–172.Google Scholar
  8. 8.
    Schrier RW: Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med 1988, 319:1065–1072. A comprehensive pathophysiologic explanation of various diseases that appear to have as a hallmark of their clinical syndrome disturbances of volume regulation, including cardiac failure, hepatic cirrhosis, and the nephrotic syndrome.PubMedCrossRefGoogle Scholar
  9. 9.
    Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med 1988, 319:1127–34. A comprehensive pathophysiologic explanation of various diseases that appear to have as a hallmark of their clinical syndrome disturbances of volume regulation, including cardiac failure, hepatic cirrhosis, and the nephrotic syndrome.PubMedCrossRefGoogle Scholar
  10. 10.
    Anand IS, Chandrashekhar Y, Ferrari R, et al.: Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993, 70:357–362. One of a few follow-up original articles that investigates the mechanisms of salt and water retention in chronic severe anemia.PubMedGoogle Scholar
  11. 11.
    Fowler NO, Holmes JC: Blood viscosity and cardiac output in acute experimental anemia. J Appl Physiol 1975, 39:453–456.PubMedGoogle Scholar
  12. 12.
    Anand IS, Chandrashekhar Y, Wander GS, Chawla LS: Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol 1995, 25:1402–1407. A study of the endothelial and vascular smooth muscle function in patients with chronic severe anemia demonstrating that enhanced basal endothelium-derived relaxing factor activity makes an important contribution to the low systemic vascular resistance in this condition.PubMedCrossRefGoogle Scholar
  13. 13.
    Ni Z, Morcos S, Vaziri ND: Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int 1997, 52:195–201.PubMedCrossRefGoogle Scholar
  14. 14.
    Epstein FH, Post RS, McDowell M: Effects of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J Clin Invest 1953, 32:233–241.PubMedGoogle Scholar
  15. 15.
    Marin-Neto JA, Maciel BC, Urbanetz LL, et al.: High output failure in patients with peripartum cardiomyopathy: a comparative study with dilated cardiomyopathy. Am Heart J 1991, 121:134–40.PubMedCrossRefGoogle Scholar
  16. 16.
    Swinburne AJ, Fedullo AJ, Gangemi R, Mijangos JA: Hereditary telangiectasia and multiple pulmonary arteriovenous fistulas. Clinical deterioration during pregnancy. Chest 1986, 89:459–460.PubMedGoogle Scholar
  17. 17.
    Korn TS, Thurston JM, Sherry CS, Kawalsky DL: High-output heart failure due to a renal arteriovenous fistula in a pregnant woman with suspected preeclampsia. Mayo Clin Proc 1998, 73:888–892.PubMedGoogle Scholar
  18. 18.
    Delorimer AA, Simpson EB, Baum RS: Hepatic artery ligation for hepatic hemangiomatosis. N Engl J Med 1967, 277:333–337.CrossRefGoogle Scholar
  19. 19.
    Brohee D, Franken P, Fievez M, et al.: High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. Arch Intern Med 1984, 144:1282–1284.PubMedCrossRefGoogle Scholar
  20. 20.
    Fowler NO, Westcott RN, Scott RC, Hess E: The cardiac output in chronic cor pulmonale. Circulation 1952, 6:888–893.PubMedGoogle Scholar
  21. 21.
    Anand IS, Chandrashekhar Y, Ferrari R, et al.: Pathogenesis of congestive state in chronic obstructive pulmonary disease. Studies of body water and sodium, renal function, hemodynamics, and plasma hormones during edema and after recovery. Circulation 1992, 86:12–21. An excellent description of the mechanisms of fluid retention in chronic obstructive pulmonary disease based of repetitive study of water and sodium spaces, renal function, hemodynamics, and plasma hormones in patients with this condition. The role of vasodilation in the pathogenesis of edema is explained.PubMedGoogle Scholar
  22. 22.
    Burrows B, Kettel LJ, Niden AH, et al.: Patterns of cardiovascular dysfunction in chronic obstructive lung disease. N Engl J Med 1972, 286:912–918.PubMedCrossRefGoogle Scholar
  23. 23.
    Richens JM, Howard P: Oedema in cor pulmonale. Clin Sci 1982, 62:255–259.PubMedGoogle Scholar
  24. 24.
    Weinberger SE, Schwartzstein RM, Weiss JW: Hypercapnia. N Engl J Med 1989, 321:1223–1231.PubMedCrossRefGoogle Scholar
  25. 25.
    Kilburn KH, Dowell AR: Renal function in respiratory failure. Effects of hypoxia, hyperoxia, and hypercapnia. Arch Intern Med 1971, 127:754–762.PubMedCrossRefGoogle Scholar
  26. 26.
    Akbarian M, Yankopoulos NA, Abelmann WH: Hemodynamic studies in beriberi heart disease. Am J Med 1966, 41:197–212.PubMedCrossRefGoogle Scholar
  27. 27.
    Martin PY, Schrier RW: Pathogenesis of water and sodium retention in cirrhosis. Kidney Int Suppl 1997, 59:S43–49. An insight into the mechanisms of the peripheral arterial vasodilation in cirrhosis, which should provide new tools in the treatment of edema and ascites, a major cause of morbidity and mortality in cirrhosis.PubMedGoogle Scholar
  28. 28.
    Schrier RW, Arroyo V, Bernardi M, et al.: Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988, 8:1151–1157.PubMedCrossRefGoogle Scholar
  29. 29.
    Niederberger M, Gines P, Tsai P, et al.: Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology 1995, 21:1625–1631.PubMedGoogle Scholar
  30. 30.
    Sogni P, Garnier P, Gadano A, et al.: Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. J Hepatol 1995, 23:471–473.PubMedCrossRefGoogle Scholar
  31. 31.
    Keller H, Bezjak V, Stegaru B, et al.: Ventricular function in cirrhosis and portasystemic shunt: a twodimensional echocardiographic study. Hepatology 1988, 8:658–662.PubMedCrossRefGoogle Scholar
  32. 32.
    Henley JW, Croxson RS, Ibbertson HK: The cardiovascular system in Paget’s disease of bone and the response to therapy with calcitonin and diphosphonate. Aust N Z J Med 1979, 9:390–397.PubMedGoogle Scholar
  33. 33.
    McIntosh HD, Miller DE, Gleason WL, Goldner JL: The circulatory dynamics of polyostotic fibrous dysplasia. Am J Med 1962, 32:393–403.CrossRefGoogle Scholar
  34. 34.
    Arnalich F, Plaza I, Sorbino JO, et al.: Cardiac size and function in Paget’s disease of bone. Int J Cardiol 1984, 5:491–505.PubMedCrossRefGoogle Scholar
  35. 35.
    Neff MS, Kim KE, Persoff M, et al.: Hemodynamics of uremic anemia. Circulation 1971, 43:876–883.PubMedGoogle Scholar
  36. 36.
    Hampl H, Schafer GE, Kessel M: Haemodynamic state in severe chronic renal failure. Pathophysiological aspects of cardiovascular function and the importance of bicarbonate dialysis. Nephron 1985, 39:102–111.PubMedCrossRefGoogle Scholar
  37. 37.
    Davison LM, Lindheimer MD: Hypertension and pregnancy. In Disease of the kidney. Edited by Schrier RW, Gottschalk C. Boston: Little Brown; 1988:1653–1686.Google Scholar
  38. 38.
    Dorup I, Skajaa K, Sorensen KE: Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol 1999, 276:H821–825.PubMedGoogle Scholar
  39. 39.
    Phippard AF, Horvath JS, Glynn EM, et al.: Circulatory adaptation to pregnancy—serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hypertens 1986, 4:773–779.PubMedCrossRefGoogle Scholar
  40. 40.
    Williams DJ, Vallance PJ, Neild GH, et al.: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748–52.PubMedGoogle Scholar
  41. 41.
    Whalen JB, Clancey CJ, Farley DB, Van Orden DE: Plasma prostaglandins in pregnancy. Obstet Gynecol 1978, 51:52–55.PubMedGoogle Scholar
  42. 42.
    Gerber JG, Payne NA, Murphy RC, Nies AS: Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance. J Clin Invest 1981, 67:632–636.PubMedGoogle Scholar
  43. 43.
    Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328:1471–1477.PubMedCrossRefGoogle Scholar
  44. 44.
    Bone RC, Fisher CJ, Jr, Clemmer TP, et al.: Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group. Crit Care Med 1989, 17:389–393.PubMedCrossRefGoogle Scholar
  45. 45.
    Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109–142.PubMedGoogle Scholar
  46. 46.
    Adolph RJ. Acquired peripheral arteriovenous fistula. In Current Therapy in Cardiovascular Disease, edn 3. Edited by Hurst JW. Philadelphia: BC Decker; 1991:409–412.Google Scholar
  47. 47.
    Cecil Textbook of Medicine, edn 20. Edited by Bennet JC, Plum F. Philadelphia: WB Saunders Co; 1996.Google Scholar
  48. 48.
    Kanis JA, Gray RE: Long-term follow-up observations on treatment in Paget’s disease of bone. Clin Orthop 1987:99–125.Google Scholar
  49. 49.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456–1462.PubMedCrossRefGoogle Scholar
  50. 50.
    Griffiths MJ, Messent M, MacAllister RJ, Evans TW: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993, 110:963–968.PubMedGoogle Scholar
  51. 51.
    Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993, 269:1829–1835.PubMedCrossRefGoogle Scholar
  52. 52.
    Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA: Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study. Crit Care Med 1998, 26:660–667. A clinical study on the hemodynamic effects of prolonged inhibition of nitric oxide synthesis with nitro-L-arginine methyl ester in patients with severe septic shock.PubMedCrossRefGoogle Scholar
  53. 53.
    Gianturco C, Anderson JH, Wallace S: Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med 1975, 124:428–435.PubMedGoogle Scholar
  54. 54.
    Wallace S, Gianturco C, Anderson JH, et al.: Therapeutic vascular occlusion utilizing steel coil technique: clinical applications. Am J Roentgenol 1976, 127:381–387.Google Scholar
  55. 55.
    Konya A, Wright KC, Wallace S: Anchoring coil embolization in a high-flow arterial model: a pilot study. J Vasc Interv Radiol 1998, 9:249–254.PubMedCrossRefGoogle Scholar
  56. 56.
    Doppman JL, Zapol W, Pierce J: Transcatheter embolization with a silicone rubber preparation. Experimental observations. Invest Radiol 1971, 6:304–309.PubMedGoogle Scholar
  57. 57.
    Takaha M, Matsumoto A, Ochi K, et al.: Intrarenal arteriovenous malformation. J Urol 1980, 124:315–318.PubMedGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Inder S. Anand
    • 1
  • Viorel G. Florea
    • 1
  1. 1.Department of CardiologyVeterans Administration Medical CenterMinneapolisUSA

Personalised recommendations